Published in Vaccine Weekly, March 2nd, 1998
The vaccine incorporates a killed, non-pathogenic Mycobacterium strain which was isolated in the 1970s from a tuberculosis patient in Madras, India.
The vaccine is scheduled to be included in India's national leprosy eradication program to complement standard therapy, reported Ganapati Mudur of New Delhi in the British Medical Journal (BMJ News, February 7, 1998;316(7129)). It is expected to be in use by June 1998; one dose will cost six Indian rupees.
According to Mudur, Dr. Rama...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.